4-methylallyloxy-3,5-dimethoxyphenethylamine (more commonly known as methallylescaline, and abbreviated as MAL) is a lesser-known psychedelic drug.

[2] Little data exists about the pharmacological properties, metabolism, and toxicity of MAL.

The effects of MAL are comparable to that of other mescaline analogs, although with a longer duration.

[5] Methallylescaline is not directly scheduled under the Controlled Substances Act.

However, due to its structural similarities with mescaline, it could potentially be prosecuted under the Federal Analogue Act if sold for human consumption.